TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Turnover |
11,025
|
11,648
|
12,784 |
Financial expenses |
183
|
162
|
38 |
Earnings before taxes |
-3,670
|
-2,274
|
-1 |
EBITDA |
-2,443
|
-1,299
|
1,173 |
Total assets |
14,720
|
18,700
|
16,997 |
Current assets |
6,244
|
6,381
|
7,158 |
Current liabilities |
7,237
|
6,394
|
3,602 |
Equity capital |
6,801
|
12,158
|
9,700 |
- share capital |
14
|
13
|
15 |
Employees (average) |
69
|
75
|
66 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Solvency |
46.2%
|
65.0%
|
57.1% |
Turnover per employee |
160
|
155
|
194 |
Profit as a percentage of turnover |
-33.3%
|
-19.5%
|
0.0% |
Return on assets (ROA) |
-23.7%
|
-11.3%
|
0.2% |
Current ratio |
86.3%
|
99.8%
|
198.7% |
Return on equity (ROE) |
-54.0%
|
-18.7%
|
0.0% |
Change turnover |
-657
|
-100
|
2,131 |
Change turnover % | -6% | 20% | |
Chg. No. of employees |
-6
|
9
|
10 |
Chg. No. of employees % | -8% | 18% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.